Nanosphere Enters Into $30 Million Common Stock Purchase Agreement With Aspire Capital
18 mars 2014 17h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 18, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has entered into a Common...
Nanosphere to Present at the 26th Annual ROTH Conference
06 mars 2014 12h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 6, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the...
Nanosphere to Host Investor Day on March 20th in New York
03 mars 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 3, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will host an Investor...
Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13
05 févr. 2013 10h07 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its results...
Nanosphere Receives FDA Clearance for C. difficile Test
10 déc. 2012 15h26 HE
|
Nanosphere, Inc.
Comprehensive sample-to-result test detects potentially deadly C. difficile and identifies 027 hypervirulent strain
Expands menu of infectious disease tests on Verigene®...
Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
29 nov. 2012 09h47 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
Nanosphere to Present at Piper Jaffray 24th Annual Healthcare Conference
21 nov. 2012 10h51 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 21, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism
13 nov. 2012 07h45 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today the US...
Nanosphere Announces Third Quarter 2012 Results
07 nov. 2012 16h01 HE
|
Nanosphere, Inc.
50 new VerigeneSP system placements double over prior quarter
C. difficile assay filed with FDA
FDA categorizes blood stream gram-positive test as CLIA moderate complexity
NORTHBROOK,...
Nanosphere to Present at Lazard Capital Markets and Stephens Inc. Investor Conferences
06 nov. 2012 09h29 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...